Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on the Mechanism of Cognitive Impairment in Patients with Moyamoya Disease

NCT06832839 is registered in ClinicalTrials.gov with Beijing Tiantan Hospital as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06832839 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on the Mechanism of Cognitive Impairment in Patients with Moyamoya Disease
Lead sponsor
Beijing Tiantan Hospital
Phase
Observational
Overall status
Recruiting
Start date
December 16, 2024
Completion date
December 31, 2027
Enrollment
360 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.